CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Study to Evaluate [18F]ACI-19626 as a Potential PET Radioligand for Imaging TDP-43 Inclusions in the Brain of Patients With Suspected TDP-43 Proteinopathies Compared With Healthy Controls

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06891716
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:42.980010+00:00
Published At: 2025-03-24T00:00:00+00:00
Record Updated At: 2025-03-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Frontotemporal Dementia (FTD)", "Amyotrophic Lateral Sclerosis (ALS)", "TDP-43 Proteinopathies", "Suspected Limbic Predominant Age-related TDP-43 Encephalopathy (LATE)", "Alzheimer\u0027s Disease (AD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-24"
protocolSection.identificationModule.nctId: "NCT06891716"
protocolSection.identificationModule.officialTitle: "Phase 1 Study to Evaluate [18F]ACI-19626 as a Potential PET Radioligand for Imaging TDP-43 Inclusions in the Brain of Patients With Suspected TDP-43 Proteinopathies Compared With Healthy Controls"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.